Vyome Therapeutics Inc. — Form D
Vyome Therapeutics Inc. of DELHI, K7, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-03. The offering totals $11.3M, of which $11.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-01-03
- Form: D
- Accession: 0001567619-19-000234
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $11.3M
- Amount sold: $11.3M
- Investors: 9
- Date of first sale: 2018-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-329563
Issuer
- Name: Vyome Therapeutics Inc.
- CIK: 0001762973
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: C/O VYOME BIOSCIENCES PVT LIMITED, DELHI, K7, 110092
- Phone: 911143034661
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Bhaskar Chaudhari | Director | Delhi, K7 |
| Chris Garabedian | Director | San Francisco, CA |
| Krishna Gupta | Director | NATICK, MA |
| Mohanjit Jolly | Director | New York, NY |
| Venkateswarlu Nelabhotla | Director | Delhi, K7 |
| Alab Rosling | Director | Delhi, K7 |
| Shiladitya Sengupta | Director | Delhi, K7 |
| Kumar Shiraigi | Director | Delhi, K7 |
| Venkateswarlu Nelabhotla | Executive Officer | Delhi, K7 |
| Venkateswarlu Nelabhotla | Promoter | Delhi, K7 |
Other filings by this issuer (1)
More